Hikma to buy sterile injectables maker Custopharm for $375m
Through the acquisition, Hikma will benefit from Custopharm’s 13 regulatory approved products, R&D professionals and a laboratory in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Sep 21
Through the acquisition, Hikma will benefit from Custopharm’s 13 regulatory approved products, R&D professionals and a laboratory in…
15 Sep 21
The Indian study was conducted to determine IgG antibody among health care workers with completed vaccine dose
23 Jun 21
ViiV Healthcare will also obtain Halozyme’s recombinant human hyaluronidase PH20 enzyme (rHuPH20) for four specific HIV medicine targets
05 May 21
Pfizer said that its first-quarter 2021 operational growth was primarily driven by the Pfizer-BioNTech Covid-19 vaccine, BNT162b2, which…
04 May 21
The investigational therapy has been designed to address the genetic deficiency of the naturally occurring enzyme which is…
12 Apr 21
With the acquisition, Sanofi is expected to benefit from a new technology platform that expands its research capabilities…
22 Mar 21
The new Covid-19 vaccine candidate is a virus like particle (VLP) triple antigen vaccine, which offers triple protection…
29 Dec 20
The generic glucagon is a synthetic version of human glucagon, a hormone that causes the liver to increase…
09 Nov 20
The acquisition will help Novo Nordisk expand its portfolio of oral biologic pipeline assets by using Emisphere’s drug…
03 Sep 20
Parnell claims that its Nomovid is an easy-to-use and low-cost nasal spray product that can be rapidly commercialised…